$107.74+$0.85 (+0.80%)as of market close, Jul 24, 2026
CVS — CVS Health Corporation stock price, chart and key statistics
Key stats
Price data
- Price
- $107.74
- Change YTD
- +34.46%
- Next earnings
- Aug 5, 2026 · Before open
- Market cap
- 137.5B
- Enterprise value
- 191.4B
- Shares outstanding
- 1.3B
- 52W low
- $58.50
- 52W high
- $110.68
- From 52W high
- -2.66%
- From 52W low
- +84.17%
- 52W range
- 94%
- Beta
- 0.60
Volume
- Rel volume
- 0.84×
- 30D volume
- 8.1M
- 30D $ vol
- 842.1M
Fundamentals
- Sales (ttm)
- 407.9B
- Sales/share
- $319.69
- EPS (ttm)
- $2.29
- FCF (ttm)
- 7.4B
- FCF/share
- $5.80
- Book value/share
- $60.71
- Net margin
- 0.72%
- ROE
- 3.79%
- ROA
- 1.16%
- Debt / equity
- 0.82×
- Current ratio
- 0.87
Growth (CAGR, ttm) · 10Y
- Sales
- +9.80%
- Net income
- -5.50%
- FCF
- +1.38%
- Shares
- +1.74%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -6.75%
- Sales/share
- +7.92%
- FCF/share
- -0.35%
- Book value/share
- +6.11%
- Dividend/share
- +6.07%
- Price
- +1.10%
- Total return
- +4.17%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 46.9×
- Fwd P/E
- 12.7×
- P/S (ttm)
- 0.3×
- P/B (mrq)
- 1.8×
- P/FCF (ttm)
- 18.6×
- EV/EBITDA (fy)
- 20.7×
- EV/Sales (ttm)
- 0.5×
- FCF yield (ttm)
- 5.38%
- Dividend yield (fwd)
- 2.47%
- Dividend/share (fwd)
- $2.66
- Buyback yield (ttm)
- 0.00%
- Shareholder yield (ttm)
- 2.48%
Vs own 10Y history
- P/E
- 95th
- P/S
- 45th
- P/B
- 72nd
- P/FCF
- 95th
Bar = where today's multiple sits in CVS's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance
1D
+0.80%
1W
+0.25%
1M
+5.76%
3M
+36.62%
YTD
+34.46%
1Y
+74.20%
5Y
+31.84%
Financial statements
Open full CVS financials →Related Consumer Staples
1MCVS Health Corporation (CVS) trades at $107.74 with a live price and an interactive chart covering 53+ years of daily price history, plus key valuation metrics. ChartRow also publishes CVS's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full CVS financial statements →